Stock Market Reviews

ASBP (Aspire Biopharma Holdings, Inc.) News

Get the latest news, insights, and market updates on ASBP (Aspire Biopharma Holdings, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Aspire Biopharma Welcomes Elite Ultra-Runner Ashley Paulson as Global Brand Ambassador for BUZZ BOMB(R) Caffeine
  A highly decorated endurance athlete, Ashley embodies the grit, energy, and rapid performance that BUZZ BOMB® was designed to support BUZZ BOMB™ will power Ashley's elite training, recovery, and lifestyle needs with its best-in-class product ...
  Dec 18, 2025 - $ASBP
• Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
  ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, received notice (the "Notice") on December 11, 2025, ...
  Dec 12, 2025 - $ASBP
• Aspire Biopharma Provides Q3 2025 Business Update
  ESTERO, FL / ACCESS Newswire / December 4, 2025 /Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today provides a business update for the quarter ended ...
  Dec 4, 2025 - $ASBP
• Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)
  ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 /Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, is pleased to announce that on November 3, 2025, ...
  Dec 2, 2025 - $ASBP
• Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member
  ESTERO, FL / ACCESS Newswire / November 26, 2025 /Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, has expanded its scientific team with the November ...
  Nov 26, 2025 - $ASBP
• BC-Most Active Stocks
  Nu Holdings Ltd. 37,382,822 15.675
  Nov 18, 2025 - $ASBP
• BC-Most Active Stocks
  EPWK Holdings Ltd. 243,983,973 0.0655
  Nov 14, 2025 - $ASBP
• Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin
  ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced its successful participation in the ...
  Nov 6, 2025 - $ASBP
• Aspire Biopharma Holdings, Inc. Announces Filing of Omnibus Patent Application for Its Innovative Sublingual Drug Delivery Platform
  ESTERO, FLORIDA / ACCESS Newswire / October 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced the filing of an omnibus patent ...
  Oct 6, 2025 - $ASBP
• Aspire Biopharma to Present at Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference - October 8-9, 2025
  Showcasing Disruptive Sublingual Drug Delivery Technology with Lead Program Targeting H2 2025 FDA Submission for Sublingual Aspirin Highlighting Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight Management) and a More-Rapid ED Medication ...
  Oct 3, 2025 - $ASBP